期刊文献+

激素避孕药在合并各种医学疾患妇女中的非避孕用途 被引量:2

Non-contraceptive use of hormonal contraceptives for women with various medical problems
下载PDF
导出
摘要 本文是我刊的国外通讯编委、Duisberg-埃森大学妇产科教授、德国埃森医学研究所主任Schindler教授的特约供稿,我们在此翻译刊出以飨读者。
出处 《生殖医学杂志》 CAS 2009年第4期327-332,共6页 Journal of Reproductive Medicine
  • 相关文献

参考文献36

  • 1SchindlerAE, Mangold K, Friedrich E, Goser R. Therapy for androgenic symptomatology with cyproterone acetate and ethinylestradiol. Arch[J].Gynecol, Obstet, 1978, 225 (2): 103-107.
  • 2Venturoli S, Paradisi R, Saviotti E, et al. Ultrasound study of ovarian and uterine morphology in women with PCOS before, during and after treatment with CPA and EE[J]. Arch Gynecol Obstet, 1985, 237(1):1 10.
  • 3Falsetti L, Gambera A, Tisi G. Efficacy of the combination ethinylestradiol and cyproterone acetate in endocrine, clinical and ultrasonic profile in polycystie ovary syndrome[J]. Hum Reprod, 2001,16(1) : 36-42.
  • 4Dramusic V, Goh VH, Rajan U,et al. Clinical, endocrinologic, and ultrasonographic features of polycystie ovary syndrome in Singaporean adolescents[J].J Pediatr Adolesc Gynecol, 1997,10(3) : 125-132.
  • 5Brown C, Ling F, Wan J. A new monophasic oral contraceptive containing drospirenone, effect on premenstrual symptoms[J]. J Reprocl Med, 2002, 47(1):14 -22.
  • 6Sangithawan M, Taneepanichskul S, Panichkul S. A comparative study of monophasie oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 btg on premenstrual symptoms[J]. Contraception, 2005, 71 (1) : 1-7.
  • 7Oelkers WH. Drospirenone in combination with estrogens for contraception and hormone replacement therapy[J]. Climacteric, 2005, 8[Suppl 3] :19-27.
  • 8Sillem M, Sehneidereit R, Teiehmann AT,et al. Anwendung des Drospirenon-haltigen oralen Kontrazeptivums im Langzyklus[J]. Frauenarzt, 2003, 44:876-881.
  • 9Batukan C, Muderris II. Efficacy of a new oral contraceptive containing drospirenone and ethinylestradiol in the long-term treatment of hirsutism[J].Fertil Steril, 2006, 85 (Z) : 436-440.
  • 10Davis AR, Westhoff C, O'Connell K, et al. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial [J].Obstet Gynecol, 2005,106(1) ..97-104.

同被引文献44

  • 1Spatzenegger M,Jaeger W.Clinical importance of hepatic cytochrome P450 in drug metabolism[J].Drug Metab Rev,1995,27(3):397-417.
  • 2Zhou S,Yung Chan S,Chef Goh B,et al.Mechanism-based inhibition of cytochrome P450 CYP3A4 by therapeutic drugs[J].Clin Pharmacokinet,2005,44(3):279-304.
  • 3Korbonen T,Tolonen A,Unsitalo J,et al.The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel[J].Br J Clin Pharmacol,2005,60(1):69-75.
  • 4Zebrowska L,Saymczyk G,Wrobel A.Adverse effects of interactions of antibiotics with other drugs[J].Pol Merkur Lekarski,2000,9(51):623-626.
  • 5Zhang H,Wang B,Cui D,et al.Pharmacokinetic drug interactions involving 17-alpha-ethinylestradiol:a new look at an old drug[J].Clin Pharmacokinet,2007,46(2):133-135.
  • 6Van Dijke CP,Weber JC.Interaction between oral contraceptives and griseofulvin[J].Br Med J(Clin Res Ed),1984,288(6424):1125-1126.
  • 7Grauford PM.Managing epilepsy in women of childbearing age[J].Drug Saf,2009,32(4):293-307.
  • 8Grauford PM.Best practice guidelines for the management of women with epilepsy[J].Epilepsia,2005,46(9):117-124.
  • 9Vrzal R,Kubesova K,Pavek P,et al.Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4:investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines[J].Toxicol Lett,2010,193(2):183-188.
  • 10Burakgazi E,Harden C,Kelly JJ.Contraception for women with epilepsy[J].Rev Neurol Dis,2009,6(2):62-67.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部